Kirsa Jeppesen-Skov

Soborg, 2860, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The effect of GIP and GLP-2 on bone turnover in children with cerebral palsy or spinal muscular atrophy.

The effect of GIP and GLP-2 on bone turnover in children with cerebral palsy or spinal muscular atrophy.

Journal: Journal of the Endocrine Society

Published: April 07, 2026

Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled study.

Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled study.

Journal: Diabetes, obesity & metabolism

Published: August 27, 2025

Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover study.

Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover study.

Journal: Diabetes, obesity & metabolism

Published: August 03, 2025

Glucose-Dependent Insulinotropic Polypeptide Is Involved in Postprandial Regulation of Splanchnic Blood Supply.

Glucose-Dependent Insulinotropic Polypeptide Is Involved in Postprandial Regulation of Splanchnic Blood Supply.

Journal: Diabetes

Published: February 12, 2025

GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly.

GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly.

Journal: The Journal of clinical endocrinology and metabolism

Published: June 18, 2024

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 09, 2023

The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans.

The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans.

Journal: European journal of endocrinology

Published: October 19, 2022

Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes.

Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes.

Journal: Bone

Published: August 30, 2022

Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis-A randomized controlled study.

Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis-A randomized controlled study.

Journal: Allergy

Published: August 12, 2022

GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes.

GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 29, 2022

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men.

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men.

Journal: Cell reports. Medicine

Published: November 08, 2021

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.

Journal: Pharmacological research

Published: August 30, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026